TSS
ADIL

Two Sigma Securities’s Adial Pharmaceuticals ADIL Stock Holding History

Two Sigma Securities’s Portfolio ADIL Stock Details ADIL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-683
Closed -$3.76K – 1612
2025
Q4 		$3.76K Buy
683
+169
+33% +$1.37K ﹤0.01% 1355
2025
Q3 		$4.54K Buy
+514
New +$5.01K ﹤0.01% 1257
2024
Q4 		– Sell
-1,085
Closed -$27.1K – 1585
2024
Q3 		$27.1K Buy
+1,085
New +$28.3K ﹤0.01% 2444
2023
Q3 		– Sell
-33
Closed -$4.31K – 2868
2023
Q2 		$4.31K Sell
33
-45
-58% -$8.13K ﹤0.01% 2680
2023
Q1 		$17.1K Buy
78
+28
+56% +$6.79K ﹤0.01% 2383
2022
Q4 		$6.75K Buy
50
+22
+79% +$3.85K ﹤0.01% 2421
2022
Q3 		$6K Buy
+28
New +$12.6K ﹤0.01% 2460

Other funds holding ADIL

Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VFT
Vanguard Fiduciary Trust Malvern, Pennsylvania $396B AUM
MCM
Manchester Capital Management Manchester, Vermont $694M AUM 22.34% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
SS
SBI Securities Tokyo, Japan $3.65B AUM 41.88% 1-Year Est. Return
CIAM
Caitong International Asset Management Hong Kong $541M AUM 1,009.51% 1-Year Est. Return

Two Sigma Securities's ADIL Position: Q1 2026 in Review

Two Sigma Securities sold out of Adial Pharmaceuticals (ADIL) in Q1 2026, closing a stake of 683 shares — an estimated $3.76K sold.

Two Sigma Securities first reported a position in ADIL in Q3 2022 and held it in 7 quarters. The position peaked at $27.1K in Q3 2024. 14 funds tracked by Wall St. Rank hold ADIL as of Q1 2026.

  • Two Sigma Securities reported no remaining Adial Pharmaceuticals position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Securities sold 683 Adial Pharmaceuticals shares in Q1 2026, an estimated $3.76K.
  • Two Sigma Securities first reported a position in Adial Pharmaceuticals in Q3 2022 and held it in 7 quarters.
  • Two Sigma Securities's Adial Pharmaceuticals position peaked at $27.1K in Q3 2024.
  • 14 funds tracked by Wall St. Rank held Adial Pharmaceuticals as of Q1 2026.

Based on Two Sigma Securities's 13F filing for Q1 2026, filed 15 May 2026.